Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1065 (LINC01065) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomously transcribed RNA molecules longer than 200 nucleotides and positioned between protein-coding genes[1][3]. LincRNAs generally do not encode proteins but may have regulatory roles in gene expression, chromatin remodeling, and the fine-tuning of neighboring gene activities[3][7]. There is currently no published evidence directly linking LINC01065 to a specific biological function, mechanism, or disease association. It is not classified as a canonical therapeutic target such as a receptor, enzyme, or transporter, and there are no known drugs that act on LINC01065. LINC01065 is annotated as a gene in databases such as NCBI Gene (accession: 102723875)[1]. The broader family of lincRNAs has a rapidly evolving functional annotation, but LINC01065 itself lacks specific mechanistic and disease involvement data as of current knowledge[1][3][7]. The molecule is not considered a therapeutic target, nor is there evidence of it being misclassified or misspelled.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1065 (LINC01065).